A Review of Western and Traditional Chinese Medical Approaches to Managing Nonalcoholic Fatty Liver Disease

<div>The natural history of NAFLD. The prevalence of NAFLD ranges from 20 to 40% in Western countries and from 5 to 40% in the Asia-Pacific area. As many as 13% (range, 6%–13%) of patients with NAFLD have histological evidence of NASH. Among them, 10% to 29% develop cirrhosis within 10 years and 27% of those patients develop HCC. HCC: hepatocellular carcinoma; NAFLD: nonalcoholic fatty liver disease; NASH: nonalcoholic steatohepatitis.</div>

Evidence-Based Complementary and Alternative Medicine

fig1

Figure 1

Figure 1: A Review of Western and Traditional Chinese Medical Approaches to Managing Nonalcoholic Fatty Liver Disease 